Methods Of Identifying Hiv Patients Sensitive To Therapy With Gp120 Cd4 Binding Site-Directed Antibodies
Patent No. EP4244396 (titled "Methods Of Identifying Hiv Patients Sensitive To Therapy With Gp120 Cd4 Binding Site-Directed Antibodies") was filed by Gilead Sciences on Nov 9, 2021. The application was issued on Aug 13, 2025.
Patent Summary
Patent Family
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents
EP4244396
- Application Number
- EP21816279A
- Filing Date
- Nov 9, 2021
- Status
- Granted And Under Opposition
- Jul 11, 2025
- Publication Date
- Aug 13, 2025
- External Links
- Slate, Register , Google Patents